Home › Job titles › Technologist
Technologist: H-1B salaries
71 labor condition applications used the job title Technologist. Median offered base salary $110,000; middle half $73,871–$130,000.
Applications (LCAs)71
Median offered salary$110,000
Middle half of salaries$73,871–$130,000
10th–90th percentile$51,626–$143,387
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Laboratory Corporation of America Holdings | 26 | $58,240 |
| California Institute of Technology/Jet Propulsion Laboratory | 24 | $133,744 |
| Alphonso Inc | 7 | $115,000 |
| Infineum USA, Inc. | 4 | $123,300 |
| Memorial Sloan Kettering Cancer Center | 3 | $104,000 |
| Laboratory Corporation of America | 3 | $56,014 |
| Laurion Capital Management LP | 1 | $200,000 |
| Credit Karma LLC | 1 | $200,476 |
| Esoterix Genetic Labs LLC | 1 | $53,996 |
| BP America Inc. | 1 | $108,243 |
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $112,362 |
| Level II (qualified) | $58,240 |
| Level III (experienced) | $123,552 |
| Level IV (fully competent) | $90,397 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 14 | $101,582 |
| FY2024 | 13 | $116,000 |
| FY2025 | 23 | $118,700 |
| FY2026 | 17 | $77,126 |
Cities
- Pasadena, CA23
- Portland, OR12
- Schaumburg, IL7
- New York, NY4
- Burlington, NC4
- Linden, NJ4
- Dublin, OH3
- Warren, MI2
- Raritan, NJ2
- Wareen, MI1
- Oakland, CA1
- Tulsa, OK1
- Pasadenca, CA1
- Shelton, CT1
- Dallas, TX1
- Chicago, IL1
- Phoenix, AZ1
- East China, MI1
- Rochester, MI1
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).